The Claim
In human ovarian granulosa tumor cells, linoleic acid at a concentration of 75 μM binds to estrogen receptors ERα (ESR1) and ERβ (ESR2), as predicted by molecular docking with binding energies of -6.9 kcal/mol and -6.1 kcal/mol respectively, and this binding is functionally associated with reduced apoptosis and inflammation, which are reversed upon ER blockade with ICI 182780, suggesting that activation of estrogen receptors may initiate downstream pathological responses.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In certain human ovarian tumor cells, a type of fat called linoleic acid sticks to estrogen receptors and seems to turn them on, which might lead to harmful effects like less cell death and more inflammation — and when scientists blocked those receptors, those effects went away.
See the scientific wording
In human ovarian granulosa tumor cells, linoleic acid at 75 μM is associated with binding to estrogen receptors ERα (ESR1) and ERβ (ESR2), as predicted by molecular docking with binding energies of -6.9 and -6.1 kcal/mol respectively, and confirmed by reversal of apoptosis and inflammation upon ER blockade with ICI 182780, suggesting ER activation may initiate downstream pathological responses.
What the research says
1 studyThe study shows that linoleic acid turns on estrogen receptors in ovarian cells, which leads to more inflammation and cell death, not less. So it contradicts the idea that this process helps protect the cells.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.